论文部分内容阅读
目的:探讨奥扎格雷钠联合血栓通治疗急性脑梗死的临床效果。方法:将我院急性脑梗死患者70例随机分为观察组和对照组,对照组给予常规综合治疗措施,观察组给予奥扎格雷钠联合血栓通治疗,评估两者治疗效果。结果:观察组总有效率明显高于对照组,2组比较差异具有统计学意义(P<0.05)。治疗后观察组患者神经功能缺损评分明显低于对照组,2组比较差异具有统计学意义(P<0.05)。2组均无明显的治疗副反应产生。结论:奥扎格雷钠联合血栓通治疗急性脑梗死的临床效果明确,安全性高,值得应用。
Objective: To investigate the clinical effect of ozagrel combined with Xueshuantong on acute cerebral infarction. Methods: Seventy patients with acute cerebral infarction in our hospital were randomly divided into the observation group and the control group. The control group was given conventional comprehensive treatment. The observation group was given sodium ozagrel combined with Xueshuantong to evaluate the therapeutic effect. Results: The total effective rate of the observation group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05). After treatment, the score of neurological deficit in the observation group was significantly lower than that of the control group, the difference between the two groups was statistically significant (P <0.05). There was no obvious side effect of treatment in the two groups. Conclusion: Ozagrel sodium combined with Xueshuantong in treating acute cerebral infarction has definite clinical effect and high safety, so it is worth to be applied.